Myriad Genetics | MYGN - Gewinn Vor Steuern

Aktienkurs
5.08
Täglich Wechseln
0.08 1.60%
Monatlich
9.48%
Jährlich
-31.35%
Q2 Prognose
4.23




Gewinn Vor Steuern Veränderung Datum
Agilent USD 442M 1000K 2025-09
Becton, Dickinson and Co. USD 393M 117M 2025-12
Bio-Rad Laboratories USD 82.9M 331.1M 2025-09
Bruker USD -72.6M 73.1M 2025-09
Danaher USD 1.08B 421M 2025-09
Illumina USD 220M 86M 2025-09
J&J USD 4.97B 2.53B 2025-12
Mettler Toledo International USD 269.24M 20.58M 2025-09
Myriad Genetics USD 4.6M 3.4M 2025-12
OraSure Technologies USD -18.43M 5.14M 2025-12
Pacific Biosciences Of California USD -40.17M 2.55M 2025-12
Quest Diagnostics USD 336M 57M 2025-09
Quidel USD -756.9M 527.3M 2025-09
Repligen USD 17.11M 10.25M 2025-09
Revvity USD 55.68M 115.97M 2025-09
Standard Biotools USD -22.03M 10.87M 2025-12
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Veracyte USD 40.63M 21.74M 2025-12
Waters USD 170.12M 7.57M 2025-09